Search clinical trials for: Dipyridamole/ Aspirin (Aggrenox)

Total 1351 results

National Institute of Diabetes and Digestive and...
Boston University; Washington University School of Medicine; University of Alabama... and other collaborators

Completed

Aggrenox Prevention of Access Stenosis (GRAFT)

Kidney Failure

United States
Boehringer Ingelheim

Completed

Headache Study to Compare Aggrenox Full Dose and Reduced Dose

Cerebrovascular Accident

Taiwan
Boehringer Ingelheim

Completed

EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA

Cerebrovascular Accident

Germany
Boehringer Ingelheim

Completed

Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers

Healthy

United States
University of Roma La Sapienza
Civic Hospital, Italy

Completed

Oxidative Stress and Oxysterols Profiling in Patients With Carotid Revascularization (ICAR)

Stroke | Cardiovascular Disease | Atherosclerosis | Carotid Stenosis

Italy
Oklahoma Medical Research Foundation

Terminated

Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE) (DARE)

Systemic Lupus Erythematosus

United States
Boehringer Ingelheim

Completed

Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers

Healthy
Boehringer Ingelheim

Completed

Mechanism of Dipyridamole Action in Platelets: in Vivo Study With Healthy Volunteers

Healthy
Rutgers, The State University of New Jersey
Boehringer Ingelheim

Completed

Aggrenox To Treat Acute Covid-19 (ATTAC-19)

Covid19

United States
Boehringer Ingelheim

Completed

Study to Compare the Effect of a Combination of Dipyridamole With Sustained Release and Acetyl Salicylic Acid (Aggrenox®) on the Performance Relevant to Safety and on the General Condition of Healthy Volunteers

Healthy
Boehringer Ingelheim

Completed

Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH

Healthy
Boehringer Ingelheim

Completed

Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients

Coronary Arteriosclerosis

Ireland
Boehringer Ingelheim

Completed

JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme

Cerebrovascular Accident

Japan
Boehringer Ingelheim
Bayer; GlaxoSmithKline

Completed

PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes

Stroke

United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Denmark, El Salvador, Finland, France, Germany, Greece, Hong Kong, India, Ireland, Israel, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, No... and more
University of Pennsylvania
Boehringer Ingelheim

Terminated

The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)

Peripheral Arterial Disease

United States
UMC Utrecht

Completed

ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial

Arteriosclerosis | Brain Ischemia | Transient Ischemic Attack

Netherlands
Boehringer Ingelheim

Completed

Effects of Acetylsalicylic Acid Compared With the Combination of Acetylsalicylic Acid + Modified-release Dipyridamole on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy Volunteers

Healthy
Emory University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Recurrent Carotid Stenosis

Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Cerebrovascular Disorders | Carotid Stenosis
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Platelet Drug Trial in Coronary Disease Progression

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease
Boehringer Ingelheim

Completed

Tolerability of Asasantin in Healthy Female and Male Subjects

Healthy
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Platelet-Inhibitor Drug Trial in Coronary Angioplasty

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease | Angina Pectoris
Boehringer Ingelheim

Completed

Pharmacokinetics and Safety of Asasantin Extended Release (RAD-SP) Capsules in Japanese Healthy Male Volunteers

Healthy
Boehringer Ingelheim

Completed

Impact of Food on Pharmacokinetics and Pharmacodynamics of Asasantin ER in Healthy Subjects

Healthy
W.L.Gore & Associates

Completed

GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients (REDUCE)

Stroke | Transient Ischemic Attack

United States, Denmark
UConn Health
United States Department of Defense

Terminated

Persantine: Variation in Response Trial

Coronary Artery Disease

United States
St George's, University of London
The Stroke Association, United Kingdom

Completed

To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection (CADISS)

Stroke | Cervical Artery Dissection | Vertebral Artery Dissection | Carotid Artery Dissection

United Kingdom
CeloNova BioSciences, Inc.
ClinLogix. LLC

Terminated

COBRA SHIELD OCT Study

Stable Angina

Finland
Radboud University Medical Center

Completed

Persantin Preceding Elective PCI (P3)

Atherosclerosis | Coronary Heart Disease | Percutaneous Transluminal Coronary Angioplasty

Netherlands
UConn Health

Terminated

Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 (TOLD)

COVID-19 Pneumonia | Vascular Complications

United States
IRCCS San Raffaele
Servier

Completed

Association Between Coronary Flow Reserve and BH4 Levels in High CV Risk

Hypertension,Essential

Italy
Radboud University Medical Center

Completed

Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?

Atherosclerosis | Ischemia-Reperfusion Injury

Netherlands
University of Michigan

Completed

Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19 (DICER)

Covid-19 | COVID | Corona Virus Infection | SARS-CoV-2 Infection

United States
Boehringer Ingelheim

Completed

Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects

Healthy
Boehringer Ingelheim

Completed

Study to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin Extended Release (ER) Formulations in Healthy Male and Female Volunteers

Healthy
Children's Hospital Medical Center, Cincinnati

Withdrawn

Dipyridamole/Magnesium To Improve Sickle Cell Hydration

Anemia, Sickle Cell

United States
University of Nottingham

Terminated

Triple Antiplatelets for Reducing Dependency After Ischaemic Stroke (TARDIS)

Stroke

United Kingdom
Sharon Riddler
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Dipyridamole for Immune Activation in HIV

HIV Infection

United States
Radboud University Medical Center

Completed

Metformin-Dipyridamole Interaction Trial (MetDipy)

Diabetes

Netherlands
Zalicus

Completed

Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis (MARS-1)

Rheumatoid Arthritis

United States, Poland, Argentina, Romania, Serbia, Canada, Estonia, Russian Federation, Lithuania, South Africa, Hungary, Mexico
Groupe Hospitalier Paris Saint Joseph

Completed

Evaluation of Rebound Effect After Withdrawal of Proton Pump Inhibitor in Geriatric Population

Proton Pump Inhibitor

France
Boehringer Ingelheim

Terminated

Study to Evaluate Pharmacokinetics of Dipyridamole in Three New Formulations of Asasantin ER in Healthy Female and Male Subjects

Healthy
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Multiple Myeloma and Plasma Cell Neoplasm

United States
Second Affiliated Hospital, School of Medicine,...

Recruiting

Antiplatelet Therapy for AIS Patients With Thrombocytopenia (PERSIST)

Thrombocytopenia | Acute Ischemic Stroke

China
Hillel Yaffe Medical Center

Unknown

"Normal Coronary Artery" With Slow Flow Improved by Adenosine Injection, Dipyridamole Treatment and Clinical Follow-up

Coronary Angiography

Israel
Aswan University Hospital

Unknown

Aspirin for Prevention of Preeclampsia

Preeclampsia

Egypt
Vanderbilt University

Completed

Treatment of Supine Hypertension in Autonomic Failure

Hypertension

United States
Clear Creek Bio, Inc.

Terminated

Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19 (CCBCRISIS04)

COVID-19

India
Assistance Publique - Hôpitaux de Paris

Completed

Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence (CLOSE)

Ischemic Stroke | Migraine | Patent Foramen Ovale | Atrial Septal Aneurysm

France
Federico II University

Completed

Platelet Aggregation in Diabetic Patients With Acute Coronary Syndrome Treated With Different Doses of Aspirin (DIABE-ASACS)

Diabetes Mellitus | Acute Coronary Syndrome

Italy
University Hospital, Lille
Ministry of Health, France; Région Hauts de France, France

Terminated

REstart or STop Antithrombotic Randomised Trial in France (RESTART-Fr)

Cerebral Hemorrhage

France

Search clinical trials for: Dipyridamole/ Aspirin (Aggrenox)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations